CASI Pharmaceuticals CASIF
OTC CASIF
$0.11 -0.02 (-15.38%)
At close: Sep 29, 2026 · 4:00 PM EDT

CASI Pharmaceuticals (CASIF) Debt Ratio (2024 - 2026)

Updated

CASI Pharmaceuticals' (CASIF) Debt Ratio came in at 1.01 for Q2 2026, up 68.1% from 0.60 a year earlier.

Analysis

CASI Pharmaceuticals (CASIF) Debt Ratio (2024 - 2026) Analysis & Trends

For FY2025, CASI Pharmaceuticals' Debt Ratio stood at 0.79, up 129.8% from FY2024.

  • In prior years, CASI Pharmaceuticals' Debt Ratio was 0.34 in FY2024.
  • The Q2 2026 figure stands as the highest quarterly Debt Ratio in data going back to Q1 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn 0.24
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn 0.52
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn 0.42
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn 0.31
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn 0.00
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn 0.60
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn 0.53
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 0.31
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn -
10 CASI Pharmaceuticals 2.26 Mn -18.56 Mn - 1.01
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.01
Dec 31, 2025 0.79
Sep 30, 2025 0.77
Jun 30, 2025 0.60
Mar 31, 2025 0.45
Dec 31, 2024 0.34
Jun 30, 2024 0.36
Mar 31, 2024 0.32
API Access

CASI Pharmaceuticals Debt Ratio API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=debt-ratio&ticker=CASIF&period=max&api_key=YOUR_API_KEY